Who
Katherine Bach Kalin
Director
Company insider
Files Form 4 as: Director, SELLAS Life Sciences Group; Director, Athersys, Inc / New.
In numbers
- Trades disclosed
- 13
- Buys
- 2
- Sells
- 0
- Bought
- $137K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 12 Nov 2020
- Last trade
- 7 Jan 2026
- Last filed
- 9 Jan 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Jan 2026filed 9 Jan 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 Nov 2025filed 21 Nov 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Bought | $101K63,400 at $1.59 | filing |
| 22 May 2025filed 22 May 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Bought | $36K20,000 at $1.80 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 10 Jan 2025filed 14 Jan 2025 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 Jan 2024filed 25 Jan 2024 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 Jan 2024filed 25 Jan 2024 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 2 Feb 2023filed 3 Feb 2023 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 2 Feb 2023filed 3 Feb 2023 | SLS SELLAS Life Sciences GroupBiotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 13 Aug 2022filed 16 Aug 2022 | SLS SELLAS Life Sciences Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 15 Jun 2021filed 15 Jun 2021 | Athersys, Inc / Newoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 12 Nov 2020filed 17 Nov 2020 | Athersys, Inc / Newoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Down – Here's WhySLS · dailypolitical.com · 20 Oct 2026SELLAS Life Sciences Group (NASDAQ:SLS) Stock Falls 11.2% – Should You Sell?SLS · tickerreport.com · 16 Oct 2026
0 headlines in the last 90 days name Katherine Bach Kalin; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.